Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PLE Reviewer - PATHOLOGY > Pathology of Breast Diseases > Flashcards

Pathology of Breast Diseases Flashcards

1
Q

Inflammatory disorder of the breast:

  • localized
  • acute inflammation
  • most common cause: Staphylococcus aureus
  • less common cause: Streptococcus pyogenes (GAS)
A

Acute mastitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Usually cause of acute mastitis associated with suppurative inflammation that may progress to abscess (single or multiple)

A

Staphylococcus aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Usually cause of acute mastitis associated with breast cellulitis

A

Streptococcus pyogenes (group A streptococci)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inflammatory disorder of the breast:

  • mimics cancer clinically
  • painless palpable mass
  • usual history of breast trauma, manipulation, or prior surgery
  • ill-defined, firm, gray-white modules containing small, chalky-white foci or dark hemorrhagic debris
  • liquefactive necrosis with neutrophils, macrophages, and eventually giant cells, calcification, and hemosiderin, leading to fibrosis
A

Fat necrosis of the breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benign epithelial lesion encompassing breast cysts, fibrosis, and adenosis

A

Fibrocystic changes of the breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fibrocystic change:

  • dilation of lobules
  • filled with brown/blue fluid (blue-dome)
  • lined with “milk of calcium” calcifications of flattened atrophic/metaplasic apocrine glands
A

Breast cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fibrocystic change:

  • caused by cyst rupture, inducing inflammation
A

Breast fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fibrocystic change:

  • increased number of acini per lobule
  • columnar cell lining with flattened epithelial atypia
A

Breast adenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benign epithelial lesion encompassing epithelial hyperplasia (typical/usual ductal hyperplasia), sclerosing adenosis, complex sclerosis, papillomas, atypical ductal hyperplasia, and atypical lobular hyperplasia

A

Proliferative breast lesions without atypia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Proliferative breast lesions without atypia:

  • > 2 layers of myoepithelial cells and luminal cells (usually 1 layer each) - heterogenous cells
  • irregular, peripheral, slit-like lumen
  • mimics ductal carcinoma-in-situ (DCIS)
A

Epithelial hyperplasia or typical/usual ductal hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Proliferative breast lesions without atypia:

  • acini more than doubled at the uninvolved lobules
  • compression at the center due to surrounding fibrosis (solid cords or double-strands of cells in densely fibrotic stroma)
  • mimics breast carcinoma
A

Sclerosing adenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Proliferative breast lesions without atypia:

  • papillary fronds with fibrovascular core growing within a dilated duct
  • bloody nipple discharge - most common cause in women younger than 50 (when intraductal)
  • develops on the lactiferous ducts or sinuses
  • no known risk for cancer
A

Breast papilloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proliferative breast lesions without atypia:

  • COMBINATION of components of epithelial cell hyperplasia, sclerosing adenosis, and papilloma
  • central nidus of entrapped glands
  • radiating projections of glands and stroma, with radial sclerosing lesion (radial scar)
  • mimics breast cancer
A

Complex sclerosis or complex sclerosis breast lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Proliferative breast lesions without atypia:

  • monomorphic cells - ductal cells only
  • round, rigid lumina = cribriform/cookie-cutter appearance
  • resembles DCIS but with limited (< 2mm) duct involvement
  • loss of 16p and gain of 17q (also in ALH nad CIS)
A

Atypical ductal hyperplasia (ADH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Proliferative breast lesions without atypia:

  • monomorphic round cells - lobular only - loosely cohesive (similar to LCIS and ILC), due to loss of E-cadherin
  • resembles LCIS but with limited (< 50%) involvement if acini per lobule
  • loss of 16p and gain of 17q (also in ADH nad CIS)
A

Atypical lobular hyperplasia (ALH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most common cancer in the adult woman, with a mean age of 64 years old; also the 2nd most common cancer producing death in women (followed by lung cancer)

A

Breast carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Benign epithelial change with the most relative risk for break cancer development

A

Carcinoma-in-situ (CIS)

(Relative risks:

  • fibrocystic changes = 1.0 or 3%
  • proliferative disease without atypia = 1.5-2.0 or 5-7%
  • proliferative disease with atypia = 4.0-5.0 or 13-17%
  • carcinoma-in-situ = 8.0-10.0 or 25-30%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Type of carcinoma-in-situ:

  • intact basement membrane
  • disrupted lobules
  • may have papillary/cribriform patterns
  • necrotic with secretory activity; thus, with calcification
  • divided into comedo and non-comedo types
  • Paget disease of the nipple observed
  • 10-20% bilateral
  • variable hormonal status (usually ER-negative and HER2-positive if with Paget disease of the nipple)
A

Ductal carcinoma-in-situ (DCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Type of carcinoma-in-situ:

  • intact basement membrane
  • lobules intact
  • WITHOUT papillary/cribriform patterns
  • usually with minimal or no necrosis or secretory activity; thus, NO calcification
  • nipple skin NOT involved, only Pagetoid spread seen
  • 20-40% bilateral
  • ER,PR-positive
  • HER2-negative
A

Lobular carcinoma-in-situ (LCIS)

20
Q

Type of ductal carcinoma-in-situ involving PLEOMORPHIC cells with high-grade hyperchromatic nuclei; and central necrosis is also observed

A

Comedo DCIS

21
Q

Type of ductal carcinoma-in-situ involving MONOMORPHIC cells varying nuclear grade (low-grade to high-grade); seen with solid, cribriform, or micropapillary patterns

A

Noncomedo DCIS

(Note: In breast cancer, the “nuclear grade” refers to the evaluation of size and shape of tumor cell nuclei; another parameter of evaluation is the mitotic figures and tubule formation which both look at cell division - Nottingham score)

22
Q

Refers to the involvement of nipple skin in DCIS, seen as a unilateral erythematous eruption/rash with scaly crusts over the nipple surface with extracellular fluid seeping out of the nipple (50-60% of cases will present with palpable mass)

A

Paget disease of the nipple

23
Q

The malignant cells involved in Paget disease of the nipple, which extend from within the ductal system into the overlying nipple skin without crossing the basement membrane via the tactiferous sinuses; usually with poorly-differentiated underlying cancer that is ER-negative and HER2-positive

A

Paget cells

24
Q

Characteristic pattern of malignant cells between the basement membrane and the overlying luminal cells NOT involving the nipple skin, as seen in LCIS

A

Pagetoid spread

25
Q

Most common type of infiltrating carcinoma of the breast, developing from a carcinoma-in-situ (DCIS) with the additional loss of its formerly intact myoepithelial layer, further described:

  • with haphazardly disposed cells with desmoplasia
  • described with the Nottingham score
A

Invasive ductal carcinoma (IDC)

26
Q

Histologic scoring system for invasive ductal carcinoma that sums following parameters:

  • tubule formation (acinar/glandular differentiation)
  • nuclear pleomorphism (nuclear grade)
  • mitotic figures (per 10 HPF)
A

Nottingham score or:

  • Nottingham histologic score
  • Elston score/grade
  • Elston-Ellis modification
  • Scarff-Bloom-Richardson grading system
  • “TNM scoring”
27
Q

Type of invasive ductal carcinoma developing from this pathway:

  1. normal breast tissue (ER-positive)
  2. GERMLINE BRCA2 MUTATION
  3. 1q, 16q and other chromosomal losses
  4. flat epithelial atypia
  5. PIK3CA mutations
  6. atypial ductal hyperplasia (ADH)
  7. CRIBRIFORM DCIS

Patient groups: BRCA2 mutation carriers, older women, male breast

Chemotherapy response: ~10%

Late-to-intermediate relapse >10 years
Long-to-intermediate survival with metastasis

A

ER-positive, HER2-negative or “luminal”

28
Q

Type of invasive ductal carcinoma developing from this pathway:

  1. normal breast tissue (ER-positive or ER-negative)
  2. GERMLINE P53 MUTATION
  3. HER2 amplification
  4. atypical apocrine adenosis
  5. MICROPAPILLARY DCIS

Patient groups: p53 mutation carriers, young women, most non-white women (ER-positive > ER-negative)

Chemotherapy response: ~15% if ER-positive; > 30% if ER-negative

Short relapse <10 years
Rare survival with metastasis

A

HER2-enriched or HER2-positive

Can be either ER-positive or ER-negative, with ER-negative responding better to treatment

29
Q

Type of invasive ductal carcinoma developing from this pathway:

  1. normal breast tissue (ER-positive or ER-negative)
  2. GERMLINE BRCA1 MUTATION
  3. secondary p53 mutations
  4. BRCA1 inactivation
  5. usually either SOLID DCIS or COMEDO DCIS

Patient groups: BRCA1 mutation carriers, young women, black women, Hispanic women

Chemotherapy response: ~30

Short relapse <5 years
Rarer survival with metastasis

A

ER-negative, HER2-negative or “basal-like”

30
Q

Type of infiltrating carcinoma of the breast known as the most common breast cancer to present as an occult primary breast cancer, further described:

  • E-cadherin or CDH1 loss
  • little desmoplasia
  • discohesive infiltrating malignant cells which may contain mucin (signet ring cells) in single file (Indian file)
  • usually ER-positive, HER2-negative
A

Invasive lobular carcinoma (ILC)

31
Q

Histologic pattern of malignant cells in invasive lobular carcinoma, described to be in a single file

A

Indian file pattern

32
Q

The malignant cells containing mucin, involved in invasive lobular carcinoma

A

Signet ring cells

33
Q

Type of infiltrating carcinoma, further described:

  • fleshy breast mass
  • syncitium-like solid sheets of large cells with pleomophic nuclei and prominent nucleoli
  • increased mitosis
  • lymphoplasmacytic infiltrates
  • “pushing borders”
  • usually ER-negative, HER2-negative
A

Medullary carcinoma

34
Q

Type of infiltrating carcinoma, further described:

  • soft/rubbery/gelatinous breast mass
  • mass consistency and appearance of pale grayish blue gelatin
  • usually ER-positive, HER2-negative
A

Mucinous carcinoma

35
Q

Type of infiltrating carcinoma, further described:

  • well-formed angulated tubules lined with a single
    layer of cells with small monomorphic nuclei
  • usually ER-positive, HER2-negative
A

Tubular carcinoma

36
Q

Type of infiltrating carcinoma, further described:

  • breast swelling with skin thickening
  • worst prognosis (3-year survival rate of 3-10%)
  • involving invasion/infiltration of the lymphatic plexus of the nipple areola
  • high degree of aneuploidy, typically high-grade
  • tumor emboli in dermal lymphatics
  • persistent E-cadherin expression
  • no particular molecular sub-type
A

Inflammatory carcinoma

37
Q

The lymphatic plexus primarily involved; invaded and infiltrated by neoplastic cells in inflammatory carcinoma

A

Sublympathic plexus of Sappey (or Sappey plexus)

38
Q

Characteristic skin thickening and dimpling appearance caused by neoplastic cell infiltration into the subareolar lymphatics as seen in inflammatory carcinoma

A

Peau d’orange

39
Q

Type of stromal tumor, further described:

  • benign
  • most common breast mass; most common benign tumor of the female breast
  • discrete, movable
  • may be painful or painless
  • increases in size during pregnancy
  • well-circumscribed, rubbery, grayish white nodules
  • proliferation may surround (pericanalicular) or compress (intracanalicular) epithelial component
  • may be further complexed with cysts (> 0.3cm), sclerosing adenosis, epithelial calcifications, and papillary apocrine change (atypical apocrine adenosis)
  • when complexed, may have a low risk of malignancy
A

Fibroadenoma

40
Q

The nodules of the breast fibroadenoma are further described to have slit-like spaces and these large, lobulated calcifications

A

Popcorn calcifications

41
Q

Type of stromal tumor, further described:

  • bulky, lobulated with cystic spaces containing leaf-like projections covered by epithelium
  • most common chromosomal abnormality: gains in 1q
  • genetic abnormality in high-grade and aggressive behavior of the tumor: HOXB13
  • stromal overgrowth
  • infiltrative borders
  • high cellularity, mitosis, and nuclear pleomorphism
A

Phyllodes tumor

42
Q

Characteristic abnormality in this gene is associated with the high-grade and aggressive behavior breast stromal tumors, especially Phyllodes tumors

A

homeobox B13 (or HOXB13)

43
Q

Male breast cancer is rare, late-presenting, and would usually have a distant metastases at time of presenation; male breast cancer usually has this ER status

A

ER-positive

44
Q

Disorder in of the male breast caused by an increase in dense collagenous connective tissue and epithelial hyperplasia of the duct lining (micropapillae), sometimes but rarely with lobule formation

A

Gynecomastia

45
Q

Characteristic presentation of the hyperplasic epithelial lining in gynecomastia

A

Micropapillae (micropapillary presentation)

PLE Reviewer - PATHOLOGY (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions